All articles — 4702 total
DTE Energy walks into its Q1 2026 earnings call this morning with the Street leaning bullish but showing clear signs of selectivity, arriving at a price — $147.03 — that has barely moved in a month but sits below most…
Kingstone Companies heads into its May 7 Q1 earnings call with short sellers in full retreat — and options traders swinging hard to the bullish side. The short covering story is the week's headline. SI % FF dropped…
D-BOX Technologies heads into May with a curious split: short sellers quietly rebuilt positions through April while the stock gained 9% on the month, and a key insider was simultaneously cutting their stake at prices…
EQ Inc. dropped a headline on April 27: a profitable fourth quarter and 28% sequential revenue growth for the 2025 year-end. The stock barely moved. That tension — a company hitting an operational inflection while the…
LADX enters the final days of April as one of the stranger stories in the OTC universe — a stock trading at penny-level prices, with a reported +855% weekly price surge, yet carrying the hallmarks of a largely dormant…
LCE enters the final days of April with a concrete operational catalyst — and a short interest picture that has dramatically quieted after weeks of volatile positioning. The story this week belongs to the demonstration…
Curtiss-Wright reports Q1 2026 results on May 6, and the week has been marked by a subtle but meaningful shift: short positions have grown at a pace that stands out, even as the stock holds near record territory. Short…
CMI heads into its May 5 Q1 results with analyst conviction running higher than the stock itself — a gap worth watching as the earnings date approaches. The Street has been busy revising upward. Multiple firms raised…
A wave of insider buying at CULP over the past six weeks has coincided with the sharpest price recovery the micro-cap textile maker has seen in months. The buying cluster is the most notable feature of the current…
CUSI is a small packaged-foods company trading on the OTC Pink Sheets at $19.85, up just over 1% on the week. The story here is less about any active market narrative and more about a thinly traded micro-cap where…
Cullen/Frost Bankers enters its Q1 2026 earnings call on April 30 with shorts unwinding sharply, options leaning bullish, and the Street split between cautious neutrals and a persistent Underweight from Morgan…
BioLife Solutions enters its May 7 Q1 2026 earnings call with an unusual split in its data: short sellers have been quietly exiting, yet the stock dropped 12.3% on the week to close at $19.99. The tension between…
Artivion enters its May 7 Q1 2026 earnings call in a state of quiet tension. The stock closed at $34.64 on April 29, down 6.5% on the week and nearly 19% year-to-date, while every analyst covering it is still rated Buy…
Crown Holdings just reported its Q1 2026 results — and the market's verdict has been a measured step back. The stock ended April 29 at $99.02, down 2.8% on the week and briefly breaking below the $100 level that served…
AMEN Properties is a rare beast in the OTC market this week — a micro-cap oil and gas royalty company trading near $496 per share that just paid a special dividend and is simultaneously drawing fresh short interest for…
Cross Timbers Royalty Trust enters May with one story dominating all others: its largest shareholder has been buying shares nearly every trading day this month, at a pace that dwarfs anything else happening with the…
Cross Country Healthcare heads into its May 7 earnings report with short sellers firmly in retreat and a stock that has quietly rebuilt from its March lows. The defining story here is the scale of short covering. Short…
CRZY closed the week at $31.00, up just under 1% on the week and about 2.5% over the past month — steady, unhurried movement that fits a thinly traded community bank on the OTC market. The most notable development this…
ANIX heads into the final days of April trading at $2.88 — down 8% on the week and 4% on Wednesday alone — even as the company secured a fresh patent win for its breast cancer vaccine technology in Mexico. The contrast…
BAK heads into the final day of April with a corporate restructuring deal reshaping its shareholder register, a surge in short positions over the past fortnight, and a law firm investigation adding fresh uncertainty to…
